RDY Stock: Dr. Reddy's Laboratories Limited Stock Price, Analysis & Insights
Get live RDY stock price $13.30, comprehensive Dr. Reddy's Laboratories Limited stock analysis, charts, news, and expert forecast. Real-time RDY stock data and investment insights.
Loading chart data...
Dr. Reddy's Laboratories Limited (RDY) Overview
Dr. Reddy's Laboratories Limited (RDY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, RDY trades at $13.30 with a market capitalization of 11.07B . Over the past 52 weeks, RDY has traded between $12.19 and $16.17 , with the current price positioned at approximately 28% of this ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 11.07B
- Current price: $13.30
- 52-week range: $12.19 - $16.17
- P/E ratio: 24.63
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Dr. Reddy's Laboratories Limited, alongside its associated companies, functions as a holistic pharmaceutical entity with a global footprint. Its business operations are divided into several key divisions. The Global Generics segment is responsible fo...
Company Information
- CEO
- Erez Israeli
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 27048
Contact Information
- Website
- https://www.drreddys.com
- Address
- 8-2-337, Road No. 3
- Country
- IN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 24.6)
✓ Lower volatility stock (Beta: 0.26) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Dr. Reddy's Laboratories Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Dr. Reddy's Laboratories Limited
- ⚠Investors should consider how Dr. Reddy's Laboratories Limited fits within their overall portfolio allocation
Market Cap
11.07B
P/E Ratio (TTM)
24.63
Beta
0.26
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare RDY with peer companies:
- Price
- $56.17
- Market cap
- 10.86B
- Price
- $103.35
- Market cap
- 10.25B
- Price
- $22.87
- Market cap
- 11.42B
- Price
- $151.65
- Market cap
- 8.86B
- Price
- $52.58
- Market cap
- 13.22B
- Price
- $160.86
- Market cap
- 16.17B
- Price
- $144.19
- Market cap
- 30.65B
- Price
- $101.29
- Market cap
- 11.30B
- Price
- $80.94
- Market cap
- 14.02B
- Price
- $15.77
- Market cap
- 18.36B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.